The company has donated 100,000 courses of its COVID-19 antiviral treatment Paxlovid to a new group aiming to improve access to the drug in low and middle-income countries.
https://www.pharmalive.com/wp-content/uploads/2022/08/ReutersPaxlovid8-19-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-07 09:04:112022-09-07 12:07:26Pfizer donates Paxlovid to group targeting COVID in poorer countries
